Xiang-dong Zhou

发表

Heping Yang, Chun-lan Tang, Xiang-dong Zhou, 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells.

X. Bian, X. Yao, W. Gong, 2006, Biochemical and biophysical research communications.

Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.

Heping Yang, Chun-lan Tang, Xiang-dong Zhou, 2017, Oncology reports.

Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer.

C. Rudin, P. Ansell, Xiang-dong Zhou, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Researche advances on CIK cells and their clinical use in lung cancer].

Xiang-dong Zhou, Hu Luo, 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Response to first-line erlotinib in a false EGFR mutation-negative patient with non-small-cell lung cancer: Make no assumptions

Xiang-dong Zhou, Hu Luo, Cai-wang Deng, 2018, Open Journal of Cell and Protein Science.

Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations

Ying Cheng, T. Mok, Yi-long Wu, 2020, Drugs.

Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798

Chun-lan Tang, Xiang-dong Zhou, Hu Luo, 2017, Oncotarget.

Effects of the regulation of polysialyltransferase ST8SiaII on the invasiveness and metastasis of small cell lung cancer cells.

Heping Yang, Xiang-dong Zhou, L. Gong, 2017, Oncology reports.

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Young Hak Kim, N. Reinmuth, A. Chiang, 2019, The Lancet.

Increased pro-angiogenic factors, infiltrating neutrophils and CD163(+) macrophages in bronchoalveolar lavage fluid from lung cancer patients.

You-hong Cui, X. Bian, Xiang-dong Zhou, 2014, International immunopharmacology.

A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors

X. Bian, X. Yao, Y. Ping, 2007, Journal of Neuro-Oncology.

Dacomitinib (daco) versus gefitinib (gef) for first-line treatment of advanced NSCLC (ARCHER 1050): Final overall survival (OS) analysis.

Ying Cheng, T. Mok, R. Rosell, 2018 .

The patient's perspective on treatment with dacomitinib: patient-reported outcomes from the Phase III trial ARCHER 1050.

J. Paty, Ying Cheng, T. Mok, 2020, Future oncology.

PREFERENTIAL EXPRESSION OF CHEMOKINE RECEPTOR CXCR4 BY HIGHLY MALIGNANT HUMAN GLIOMAS AND ITS ASSOCIATION WITH POOR PATIENT SURVIVAL

X. Bian, Y. Ping, W. Gong, 2007, Neurosurgery.

The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells

X. Bian, X. Yao, Y. Ping, 2007, Journal of Neuro-Oncology.

Expression of SHP2 and Related Markers in Non–Small Cell Lung Cancer: A Tissue Microarray Study of 80 Cases

Qingliang Wang, Heping Yang, Chun-lan Tang, 2013, Applied immunohistochemistry & molecular morphology (Print).

The signaling and transformation potency of the overexpressed HER2 protein is dependent on the normally-expressed EGFR.

Y. Agazie, Xiang-dong Zhou, 2012, Cellular signalling.

SHP2在非小细胞肺癌中的表达及意义

Qingliang Wang, Heping Yang, Chun-lan Tang, 2010, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[Construction and expression of recombinant prokaryotic vector PGEX-4T-1-BC006151 correlated with multidrug resistant of lung adenocarcinoma.].

Heping Yang, Xiang-dong Zhou, Xuejun Li, 2008, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.

Xianglin Shi, B. Jiang, Jing Fang, 2007, Cancer research.

EMT and Acquisition of Stem Cell-Like Properties Are Involved in Spontaneous Formation of Tumorigenic Hybrids between Lung Cancer and Bone Marrow-Derived Mesenchymal Stem Cells

Dan Luo, Wei Xiong, Xiang-Dong Zhou, 2014, PloS one.

Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial.

Ying Cheng, T. Mok, Yi-long Wu, 2017, The Lancet. Oncology.

Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines.

X. Bian, Xiang-dong Zhou, Hu Luo, 2013, Oncology reports.

Molecular characterization of clinical responses to PD‐1/PD‐L1 inhibitors in non‐small cell lung cancer: Predictive value of multidimensional immunomarker detection for the efficacy of PD‐1 inhibitors in Chinese patients

C. Bai, Li Zhang, F. Jin, 2019, Thoracic cancer.

Molecular Mechanism for SHP2 in Promoting HER2-induced Signaling and Transformation*

Y. Agazie, Xiang-dong Zhou, 2009, Journal of Biological Chemistry.

A cohort autopsy study defines COVID-19 systemic pathogenesis

X. Bian, X. Yao, Y. Ping, 2021, Cell Research.

PI3K/AKT通路在肺癌转移和耐药中的研究

Xiang-dong Zhou, Bingjing Zhu, 冰晶 Bingjing 祝 ZHU, 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Autophagy Accompanied with Bisdemethoxycurcumin-induced Apoptosis in Non-small Cell Lung Cancer Cells.

Heping Yang, Chun-lan Tang, Xiang-dong Zhou, 2015, Biomedical and environmental sciences : BES.

CA 916798 Regulates Multidrug Resistance of Lung Cancer Cells

W. Xiong, Heping Yang, Xiang-dong Zhou, 2012 .

The Tyrosine Phosphatase SHP2: A Key Molecule Linked both Type 2Diabetes and Cancers?

Chun-lan Tang, Xiang-dong Zhou, Hu Luo, 2014 .

Differential effects of mesenchymal stem cells on a heterogeneous cell population within lung cancer cell lines

Xiang-dong Zhou, D. Luo, Dengqun Liu, 2013, Molecular and Cellular Biochemistry.

Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050).

Ying Cheng, T. Mok, Yi-long Wu, 2021, Lung cancer.

Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.

Xiangdong Zhou, Maria Rita Migliorino, Kazuhiko Nakagawa, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dacomitinib versus gefitinib for the first-line treatment of advanced EGFR mutation positive non-small cell lung cancer (ARCHER 1050): A randomized, open-label phase III trial.

Ying Cheng, T. Mok, Yi-long Wu, 2017 .

The Value of Serum Prealbumin in the Diagnosis and Therapeutic Response of Tuberculosis: A Retrospective Study

Xiang-dong Zhou, L. Gong, Hu Luo, 2013, PloS one.

Tumor Vascularity and Glucose Metabolism Correlated in Adenocarcinoma, but Not in Squamous Cell Carcinoma of the Lung

Lihua Chen, Jian Wang, Jiuquan Zhang, 2014, PloS one.

P-selectin-mediated platelet activation promotes adhesion of non-small cell lung carcinoma cells on vascular endothelial cells under flow

Heping Yang, Xiang-dong Zhou, L. Gong, 2012, Molecular medicine reports.

[Cloning and sequence analysis of a new, full-length cDNA fragment of drug resistance-related gene in human lung adenocarcinoma].

Xiang-dong Zhou, Gui-jun Huang, G. Qian, 2002, Ai zheng = Aizheng = Chinese journal of cancer.

Activated Platelets Interact with Lung Cancer Cells Through P-Selectin Glycoprotein Ligand-1

Yun Cai, Heping Yang, Xiang-dong Zhou, 2012, Pathology & Oncology Research.

Relationship between Apparent Diffusion Coefficient and Tumour Cellularity in Lung Cancer

Lihua Chen, Jian Wang, Jiuquan Zhang, 2014, PloS one.

Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II Trial

Qi Zhou, Zhi Xu, Haidong Wang, 2019, Clinical Cancer Research.

Bone marrow-derived cells contribute to NDEA-induced lung squamous cell carcinoma

Chun-lan Tang, Xiang-dong Zhou, D. Luo, 2013, Tumor Biology.

The IncP-6 Plasmid p10265-KPC from Pseudomonas aeruginosa Carries a Novel ΔISEc33-Associated blaKPC-2 Gene Cluster

Xiang-dong Zhou, Dongsheng Zhou, Xiao-tian Dai, 2016, Front. Microbiol..

Role of Wnt Inhibitory Factor-1 in Inhibition of Bisdemethoxycurcumin Mediated Epithelial-to-Mesenchymal Transition in Highly Metastatic Lung Cancer 95D Cells

Heping Yang, Chun-lan Tang, Xiang-dong Zhou, 2015, Chinese medical journal.

Phase I safety and pharmacokinetic (PK) study of veliparib in combination with whole brain radiation therapy (WBRT) in patients (pts) with brain metastases.

W. Curran, M. Mehta, V. Giranda, 2012 .

Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib.

D. Carbone, Yangming Ou, Likun Chen, 2019, Lung Cancer.

Akt1 Enhances CA916798 Expression through mTOR Pathway

Xiang-dong Zhou, Haijing Wang, Bingjing Zhu, 2013, PloS one.

CA916798 gene expression is associated with multidrug resistance and predicts progression-free survival in patients with lung cancer

Xiang-dong Zhou, Lan Liang, Zaixing Yang, 2019, Oncology letters.

Identification of CD 90 as a marker for lung cancer stem cells in A 549 and H 446 cell lines

X. Bian, Xiang-dong Zhou, Hu Luo, 2022 .

Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.

Xiang-dong Zhou, Tong-hua Mei, Lian Li, 2009, Ai zheng = Aizheng = Chinese journal of cancer.

Oral administration of oleanolic acid, isolated from Swertia mussotii Franch, attenuates liver injury, inflammation, and cholestasis in bile duct-ligated rats.

Xin-chan Feng, Xiang-dong Zhou, Wensheng Chen, 2015, International journal of clinical and experimental medicine.

Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling

Heping Yang, Xiang-dong Zhou, Xiao-tian Dai, 2017, Apoptosis.

[CA916798 gene participates in cisplatin resistance of human lung adenocarcinoma A549 cells through PI3K/AKT/mTOR pathway].

Xiang-dong Zhou, Yuliang Wang, Zhanzhong Qi, 2012, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

CA916798 regulates multidrug resistance of lung cancer cells.

W. Xiong, Heping Yang, Xiang-dong Zhou, 2011, Asian Pacific journal of cancer prevention : APJCP.

Unique proteomic features induced by a potential antiglioma agent, Nordy (dl‐nordihydroguaiaretic acid), in glioma cells

X. Bian, Y. Ping, Ji Ming Wang, 2008, Proteomics.

Anti-angiogenesis effect of Demethyl bryoanthrathiophene (DBT) in vitro

C. Zhong, Xiang-dong Zhou, Minghui Zhang, 2011 .

Differential effects of mesenchymal stem cells on a heterogeneous cell population within lung cancer cell lines

Xiang-dong Zhou, D. Luo, Dengqun Liu, 2013, Molecular and Cellular Biochemistry.

Inhibition of DNA methyltransferase 1 by RNA interference reverses epithelial-mesenchymal transition in highly metastatic 95D lung cancer cells by inhibiting the Wnt signaling pathway

Heping Yang, Xiang-dong Zhou, Xiangyan Zhang, 2018, Oncology letters.